At ThinkGenetic, Inc. our goal is to reduce the time to diagnosis for genetic and rare conditions. Given they are rare, we must be cognizant of the time it takes […]
Guardian Research Network, Inc.® (GRN) and ThinkGenetic, Inc. announce a strategic collaboration to accelerate the diagnosis and support the development of treatment options for patients with rare and genetic diseases.
Development and implementation of an automated severity scoring system to identify patients at possible increased risk for specific genetic conditions NSGC 2021 Poster UM353
Most medical treatments fall into four broad categories based on their goal: For the most part, treatments for genetic diseases have fallen into the preventive, disease management, or palliative categories. […]
New Partnership Strengthens ThinkGenetic’s Continued Effort to Reduce Time to Diagnosis In an influential move for the genetics community, ThinkGenetic (ThinkGenetic.com) and Genome Medical (GenomeMedical.com), a nationwide specialty medical practice […]